There is quite a bit of underperformance in Indian market volatility compared to US market volatility since the COVID-19 crash as indicated by the jaws gap below. This should resolve soon with an upcoming spike in Indian market volatility and a significant fall in the Nifty Index.
Immuneering (NASDAQ:IMRX) Stock Price Expected to Rise, Mizuho Analyst Says
-
Immuneering (NASDAQ:IMRX – Get Free Report) had its price target boosted by
Mizuho from $8.00 to $10.00 in a research report issued to clients and
investor...
26 minutes ago
No comments:
Post a Comment